论文部分内容阅读
试用间接迁移抑制试验检查29例自身免疫性慢活肝患者,26例肝特异性脂蛋白(LSP)阳性患者示存在T淋巴细胞迁移抑制因子(T-LIF),而21例HBsAg阳性慢性肝病患者中仅1例示T-LIF阳性,19例对照者无1例阳性.虽然5例自身免疫性甲状腺病患者,在甲状腺膜抗原存在的情况下,其T淋巴细胞可产生T-LIF,但在对LSP应答反应中均未检出T-LIF,1例患自身免疫性肝病和甲状腺病患者的T淋巴细胞在LSP和甲状腺膜抗原存在的情况下产生T-LIF,若将自身免疫性慢活肝T淋巴细
A total of 29 patients with autoimmune slow-acting liver were tested in indirect immunosuppression trial. T-lymphocyte migration inhibitory factor (T-LIF) was detected in 26 patients with positive liver-specific lipoprotein (LSP), while 21 patients with HBsAg-positive chronic liver disease Only 1 case showed positive T-LIF, and none of the 19 cases was positive.Although T-LIF was expressed in T lymphocytes in 5 patients with autoimmune thyroid disease in the presence of thyroid membrane antigen, T-LIF was not detected in the response to LSP, T-LIF in one patient with autoimmune liver disease and thyroid disease, and T-LIF in the presence of LSP and thyroid membrane antigen. If autoimmune slow-living liver T lymphocytes